Concepedia

Anke Loregger

AL

Statistics

Publications

17

Citations

737

H-Index

15

Active since

2014

Affiliations

University of Amsterdam(Current)

Amsterdam UMC Location University of Amsterdam

Amsterdam University Medical Centers

University of Groningen

The Netherlands Cancer Institute

Anke Loregger is an author at University of Amsterdam specializing in life sciences, molecular biology, and biochemistry.

Publications per year

2014–2025

17

Publications

17

The E3 Ubiquitin Ligase MARCH6 Degrades Squalene Monooxygenase and Affects 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase and the Cholesterol Synthesis Pathway

Noam Zelcer, Laura J. Sharpe, Anke Loregger et al. · Molecular and Cellular Biology · 2014 · 177 citations · Full text

, , +16

The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane

Anke Loregger, Martina Grandl, Raquel Mejías‐Luque et al. · Science Signaling · 2015 · 76 citations · Full text

, , +15

Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism

Anke Loregger, Matthijs Raaben, Joppe Nieuwenhuis et al. · Nature Communications · 2020 · 50 citations · Full text

, , +14

Identification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism

Xifeng Lu, Marcel E. Meima, Jessica K. Nelson et al. · Circulation Research · 2015 · 48 citations · Full text

, , +13

Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis

Josephine M. E. Tan, Emma C. L. Cook, Marlene van den Berg et al. · Atherosclerosis · 2018 · 45 citations · Full text

, , +17

1–5 of 17